Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Syneron stock falls after approval delayed NEW YORK -- Syneron Medical Ltd. stock fell Tuesday after the US Food and Drug Administration delayed approval of the medical device maker #39;s cellulite product.
